A citation-based method for searching scientific literature

Nayim Sepay, Aishwarya Sekar, Umesh C Halder, Abdullah Alarifi, Mohd Afzal. J Mol Struct 2021
Times Cited: 12







List of co-cited articles
73 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds.
Anh-Tien Ton, Francesco Gentile, Michael Hsing, Fuqiang Ban, Artem Cherkasov. Mol Inform 2020
195
33

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
25

Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants.
Gideon A Gyebi, Olalekan B Ogunro, Adegbenro P Adegunloye, Oludare M Ogunyemi, Saheed O Afolabi. J Biomol Struct Dyn 2021
79
25

Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil.
Bui Thi Phuong Thuy, Tran Thi Ai My, Nguyen Thi Thanh Hai, Le Trung Hieu, Tran Thai Hoa, Huynh Thi Phuong Loan, Nguyen Thanh Triet, Tran Thi Van Anh, Phan Tu Quy, Pham Van Tat,[...]. ACS Omega 2020
79
25

Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach.
Selvaraj Alagu Lakshmi, Raja Mohamed Beema Shafreen, Arumugam Priya, Karutha Pandian Shunmugiah. J Biomol Struct Dyn 2021
20
25

Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants.
Muhammad Tahir Ul Qamar, Safar M Alqahtani, Mubarak A Alamri, Ling-Ling Chen. J Pharm Anal 2020
342
25

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences.
Rohan R Narkhede, Ashwini V Pise, Rameshwar S Cheke, Sachin D Shinde. Nat Prod Bioprospect 2020
43
25

Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.
Olga Abian, David Ortega-Alarcon, Ana Jimenez-Alesanco, Laura Ceballos-Laita, Sonia Vega, Hugh T Reyburn, Bruno Rizzuti, Adrian Velazquez-Campoy. Int J Biol Macromol 2020
70
25

In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Taha A Hussien, Esraa A A Badr, Tarik A Mohamed, Hesham R El-Seedi, Paul W Pare, Thomas Efferth, Mohamed-Elamir F Hegazy. Comput Biol Med 2020
42
25

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
25

Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study.
Muhammad Tahir Khan, Arif Ali, Qiankun Wang, Muhammad Irfan, Abbas Khan, Muhammad Tariq Zeb, Yu-Juan Zhang, Sathishkumar Chinnasamy, Dong-Qing Wei. J Biomol Struct Dyn 2021
61
25

Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.
Davide Gentile, Vincenzo Patamia, Angela Scala, Maria Teresa Sciortino, Anna Piperno, Antonio Rescifina. Mar Drugs 2020
104
25

The SARS-CoV-2 main protease as drug target.
Sven Ullrich, Christoph Nitsche. Bioorg Med Chem Lett 2020
162
25

Molecular properties that influence the oral bioavailability of drug candidates.
Daniel F Veber, Stephen R Johnson, Hung-Yuan Cheng, Brian R Smith, Keith W Ward, Kenneth D Kopple. J Med Chem 2002
25

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.
Garrett M Morris, Ruth Huey, William Lindstrom, Michel F Sanner, Richard K Belew, David S Goodsell, Arthur J Olson. J Comput Chem 2009
25

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang,[...]. Nature 2020
16

The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
Jrhau Lung, Yu-Shih Lin, Yao-Hsu Yang, Yu-Lun Chou, Li-Hsin Shu, Yu-Ching Cheng, Hung Te Liu, Ching-Yuan Wu. J Med Virol 2020
107
16

SARS and MERS: recent insights into emerging coronaviruses.
Emmie de Wit, Neeltje van Doremalen, Darryl Falzarano, Vincent J Munster. Nat Rev Microbiol 2016
16

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.
Canrong Wu, Yang Liu, Yueying Yang, Peng Zhang, Wu Zhong, Yali Wang, Qiqi Wang, Yang Xu, Mingxue Li, Xingzhou Li,[...]. Acta Pharm Sin B 2020
830
16

Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
Syed Ovais Aftab, Muhammad Zubair Ghouri, Muhammad Umer Masood, Zeshan Haider, Zulqurnain Khan, Aftab Ahmad, Nayla Munawar. J Transl Med 2020
55
16

COVID-19: A promising cure for the global panic.
Balachandar Vellingiri, Kaavya Jayaramayya, Mahalaxmi Iyer, Arul Narayanasamy, Vivekanandhan Govindasamy, Bupesh Giridharan, Singaravelu Ganesan, Anila Venugopal, Dhivya Venkatesan, Harsha Ganesan,[...]. Sci Total Environ 2020
199
16


Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease.
Rakesh S Joshi, Shounak S Jagdale, Sneha B Bansode, S Shiva Shankar, Meenakshi B Tellis, Vaibhav Kumar Pandya, Anita Chugh, Ashok P Giri, Mahesh J Kulkarni. J Biomol Struct Dyn 2021
139
16

Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis.
Rajaiah Alexpandi, Joelma Freire De Mesquita, Shunmugiah Karutha Pandian, Arumugam Veera Ravi. Front Microbiol 2020
35
16

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Qiaofa Lu,[...]. Lancet 2020
16

Molecular docking: a powerful approach for structure-based drug discovery.
Xuan-Yu Meng, Hong-Xing Zhang, Mihaly Mezei, Meng Cui. Curr Comput Aided Drug Des 2011
542
16

Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event.
D Paraskevis, E G Kostaki, G Magiorkinis, G Panayiotakopoulos, G Sourvinos, S Tsiodras. Infect Genet Evol 2020
286
16

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Bin Cao, Yeming Wang, Danning Wen, Wen Liu, Jingli Wang, Guohui Fan, Lianguo Ruan, Bin Song, Yanping Cai, Ming Wei,[...]. N Engl J Med 2020
16



Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach.
Rupesh V Chikhale, Shailendra S Gurav, Rajesh B Patil, Saurabh K Sinha, Satyendra K Prasad, Anshul Shakya, Sushant K Shrivastava, Nilambari S Gurav, Rupali S Prasad. J Biomol Struct Dyn 2021
40
16

Evaluation of the Inhibitory Activities of COVID-19 of Melaleuca cajuputi Oil Using Docking Simulation.
Tran Thi Ai My, Huynh Thi Phuong Loan, Nguyen Thi Thanh Hai, Le Trung Hieu, Tran Thai Hoa, Bui Thi Phuong Thuy, Duong Tuan Quang, Nguyen Thanh Triet, Tran Thi Van Anh, Nguyen Thi Xuan Dieu,[...]. ChemistrySelect 2020
8
25

Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches.
Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Tyagi, Arvind Bhushan, Madhu Rathore. J Biomol Struct Dyn 2021
60
16

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
Laura Riva, Shuofeng Yuan, Xin Yin, Laura Martin-Sancho, Naoko Matsunaga, Lars Pache, Sebastian Burgstaller-Muehlbacher, Paul D De Jesus, Peter Teriete, Mitchell V Hull,[...]. Nature 2020
295
16

Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.
Andresa Aparecida Berretta, Marcelo Augusto Duarte Silveira, José Manuel Cóndor Capcha, David De Jong. Biomed Pharmacother 2020
47
16

Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach.
Ziyad Tariq Muhseen, Alaa R Hameed, Halah M H Al-Hasani, Muhammad Tahir Ul Qamar, Guanglin Li. J Mol Liq 2020
34
16


Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells.
K J Senthil Kumar, M Gokila Vani, Chung-Shuan Wang, Chia-Chi Chen, Yu-Chien Chen, Li-Ping Lu, Ching-Hsiang Huang, Chien-Sing Lai, Sheng-Yang Wang. Plants (Basel) 2020
29
16

Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein.
Seema A Kulkarni, Santhosh Kumar Nagarajan, Veena Ramesh, Velusamy Palaniyandi, S Periyar Selvam, Thirumurthy Madhavan. J Mol Struct 2020
36
16

Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development.
Preeti Pandey, Jitendra Subhash Rane, Aroni Chatterjee, Abhijeet Kumar, Rajni Khan, Amresh Prakash, Shashikant Ray. J Biomol Struct Dyn 2021
73
16

In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2.
Sathish Kumar Chidambaram, Daoud Ali, Saud Alarifi, Surendrakumar Radhakrishnan, Idhayadhulla Akbar. J Infect Public Health 2020
8
25


How Big Is Too Big for Cell Permeability?
Pär Matsson, Jan Kihlberg. J Med Chem 2017
70
16

Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro).
Ahmed M Sayed, Hani A Alhadrami, Ahmed O El-Gendy, Yara I Shamikh, Lassaad Belbahri, Hossam M Hassan, Usama Ramadan Abdelmohsen, Mostafa E Rateb. Microorganisms 2020
30
16

The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation.
Doaa A Abdelrheem, Shimaa A Ahmed, H R Abd El-Mageed, Hussein S Mohamed, Aziz A Rahman, Khaled N M Elsayed, Sayed A Ahmed. J Environ Sci Health A Tox Hazard Subst Environ Eng 2020
13
16


The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Leon Caly, Julian D Druce, Mike G Catton, David A Jans, Kylie M Wagstaff. Antiviral Res 2020
765
16

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
16

Bioactive compounds from marine resources against novel corona virus (2019-nCoV): in silico study for corona viral drug.
R Vijayaraj, K Altaff, A Sherlin Rosita, S Ramadevi, J Revathy. Nat Prod Res 2021
9
22

In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19.
Rupesh V Chikhale, Saurabh K Sinha, Rajesh B Patil, Satyendra K Prasad, Anshul Shakya, Nilambari Gurav, Rupali Prasad, Suhas R Dhaswadikar, Manish Wanjari, Shailendra S Gurav. J Biomol Struct Dyn 2021
29
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.